<DOC>
	<DOC>NCT00517621</DOC>
	<brief_summary>validation of a french version of FACT-GOG/NTX and using this questionnaire to evaluate the incidence of the peripheral neurotoxicity in patients treated for ovarian cancer with paclitaxel associated or not with EPO.</brief_summary>
	<brief_title>Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity &amp; Validation of a French Version of This Questionnaire</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Neurotoxicity Syndromes</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Femal patient aged &gt; 18 years Histologically proven diagnosis of cancer of the ovary, the fallopian tube or peritoneal patients whose disease progresses or relapses patients having received at least a line of platinumbased chemotherapy patients whose treatment of relapse is envisaged to comprise paclitaxel patients who will receive EPO for treatment of their anaemia ECOG performans status &lt; 2 life expectancy &gt; 16 weeks patient who has clearly given her consent by signing on informed consent form prior to participation peripheral neuropathy grade &gt; 2 history of ischemic cardiopathy, congestive heart failure (NYHA&gt;2), arrhythmia, hypertension or significant valvulopathy abnormal biological values A therapy or a serious disease which could involve a risk for the patient or interfere with the aims of the study patient who is pregnant, breast feeding or using inadequate contraception concomitant therapy by a potentially neurotoxic drug concomitant inclusion in another therapeutic trial which could interfere with the aims of the study patient who for familial, sociological, geographical or psychological condition could not be followed correctly</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Peritoneal cancer</keyword>
	<keyword>Relapse or progression</keyword>
</DOC>